Completed
Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or Lymphoma
NCT00631579
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Hyperuricemia, +10 more
- Locations
-
- Sanofi-Aventis Tokyo, Japan